Eyetamins is a healthcare technology and life sciences company focused on therapeutics and consumer innovations in the $200B eye health and wellness space. They launched the company with natural supplements for eye health, which is a $37B industry. They have a patent-pending formula for dry eye, which is an $8B untapped market.
Andrew Malloy spent a career on Wall Street and also happens to be part of a 3rd generation family office created because of his...
Richard Lehman, MD does not let moss grow under his feet. As you will hear in this episode, he is involved in the whole...
Mark Cherney is the Founder and Executive Chairman of both US Urology Partners and Prologics. This past year Mark transitioned from the CEO role...
